Black Diamond Therapeutics, Inc vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
8.3
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
BDTX
High-quality business with 23% return on equity and 32% profit margins.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $9.86 (+279.1%)
7 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
BDTX
JNJ
6.7×
Trailing P/E
26.3×
-2.5×
Forward P/E
17.9×
32.0%
Profit Margin
21.8%
100.0%
Gross Margin
68.0%
22.9%
ROE
26.4%
—
Revenue Growth
9.9%
—
Earnings Growth
-52.9%
3.39
Beta
0.33
—
Price / Book
—
$149M
Market Cap
$546.9B
$1 – $5
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →